Like STAT3, COX2 is a pleiotropic factor involved in tumor initiation, progression, and inflammatory signaling [49] (Figure 1) and COX-2 inhibitors decrease the incidence of gastrointestinal tumors in mice and humans as well as a subset of tumors arising in other tissues. Here, PTGS2 is linked to digestive system neoplasm.